{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T16:34:15Z","timestamp":1792946055101,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.conctc.2026.101693","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:17:19Z","timestamp":1790810239000},"page":"101693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inclusion of historical control data in the analysis of a current trial for zero-inflated count models"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4963-5264","authenticated-orcid":false,"given":"Akalu Banbeta","family":"Tereda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Legesse Kassa","family":"Debusho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.conctc.2026.101693_b1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials\u2014the gold standard for effectiveness research: Study design: randomised controlled trials","volume":"125","author":"Hariton","year":"2018","journal-title":"BJOG: Int. J. Obs. Gynaecol."},{"issue":"1","key":"10.1016\/j.conctc.2026.101693_b2","first-page":"1","article-title":"A review of dynamic borrowing methods with applications in pharmaceutical research. Brazilian journal of probability and statistics","volume":"38","author":"Lesaffre","year":"2024","journal-title":"J. Valid. Technol."},{"key":"10.1016\/j.conctc.2026.101693_b3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0021-9681(76)90044-8","article-title":"The combination of randomized and historical controls in clinical trials","volume":"29","author":"Pocock","year":"1976","journal-title":"J. Chronic Dis."},{"issue":"1","key":"10.1016\/j.conctc.2026.101693_b4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pst.1589","article-title":"Use of historical control data for assessing treatment effects in clinical trials","volume":"13","author":"Viele","year":"2014","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.conctc.2026.101693_b5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1541-0420.2011.01564.x","article-title":"Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials","volume":"67","author":"Hobbs","year":"2011","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.conctc.2026.101693_b6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/19466315.2016.1174149","article-title":"On the use of co-data in clinical trials","volume":"8","author":"Neuenschwander","year":"2016","journal-title":"Stat. Biopharm. Res."},{"key":"10.1016\/j.conctc.2026.101693_b7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1740774509356002","article-title":"Summarizing historical information on controls in clinical trials","volume":"7","author":"Neuenschwander","year":"2010","journal-title":"Clin. Trials"},{"key":"10.1016\/j.conctc.2026.101693_b8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/biom.12242","article-title":"Robust meta-analytic-predictive priors in clinical trials with historical control information","volume":"70","author":"Schmidli","year":"2014","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.conctc.2026.101693_b9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/pst.2178","article-title":"The power prior with multiple historical controls for the linear regression model","volume":"21","author":"Banbeta","year":"2022","journal-title":"Pharm. Stat."},{"issue":"1","key":"10.1016\/j.conctc.2026.101693_b10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/19466315.2023.2190933","article-title":"Bayesian Borrowing methods for count data: Analysis of incontinence episodes in patients with overactive bladder","volume":"16","author":"Banbeta","year":"2024","journal-title":"Stat. Biopharm. Res."},{"issue":"2","key":"10.1016\/j.conctc.2026.101693_b11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/pst.1664","article-title":"The analysis of incontinence episodes and other count data in patients with overactive bladder by Poisson and negative binomial regression","volume":"14","author":"Martina","year":"2015","journal-title":"Pharm. Stat."},{"issue":"1","key":"10.1016\/j.conctc.2026.101693_b12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/1269547","article-title":"Zero-inflated Poisson regression, with an application to defects in manufacturing","volume":"34","author":"Lambert","year":"1992","journal-title":"Technometrics"},{"key":"10.1016\/j.conctc.2026.101693_b13","series-title":"Negative Binomial Regression","author":"Hilbe","year":"2011"},{"key":"10.1016\/j.conctc.2026.101693_b14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1214\/ss\/1009212673","article-title":"Power prior distributions for regression models","volume":"15","author":"Ibrahim","year":"2000","journal-title":"Statist. Sci."},{"issue":"28","key":"10.1016\/j.conctc.2026.101693_b15","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1002\/sim.6728","article-title":"The power prior: theory and applications","volume":"34","author":"Ibrahim","year":"2015","journal-title":"Stat. Med."},{"issue":"7","key":"10.1016\/j.conctc.2026.101693_b16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/sim.8019","article-title":"Modified power prior with multiple historical trials for binary endpoints","volume":"38","author":"Banbeta","year":"2019","journal-title":"Stat. Med."},{"key":"10.1016\/j.conctc.2026.101693_b17","series-title":"Regression Analysis of Count Data","author":"Cameron","year":"2013"},{"key":"10.1016\/j.conctc.2026.101693_b18","unstructured":"W.H. Greene, Accounting for Excess Zeros and Sample Selection in Poisson and Negative Binomial Regression Models, NYU Working Paper, 1994."},{"key":"10.1016\/j.conctc.2026.101693_b19","doi-asserted-by":"crossref","DOI":"10.1002\/jrsm.1561","article-title":"Incorporating historical control information in ANCOVA models using the meta-analytic-predictive approach","author":"Qi","year":"2022","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.conctc.2026.101693_b20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/env.752","article-title":"Evaluating water quality using power priors to incorporate historical information","volume":"17","author":"Duan","year":"2006","journal-title":"Environmetrics"},{"key":"10.1016\/j.conctc.2026.101693_b21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1214\/ss\/1028905934","article-title":"Simulating normalizing constants: From importance sampling to bridge sampling to path sampling","author":"Gelman","year":"1998","journal-title":"Statist. Sci."},{"key":"10.1016\/j.conctc.2026.101693_b22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1467-9868.2007.00650.x","article-title":"Marginal likelihood estimation via power posteriors","volume":"80","author":"Friel","year":"2008","journal-title":"J. R. Stat. Soc.: Ser. B (Statistical Methodol."},{"issue":"2","key":"10.1016\/j.conctc.2026.101693_b23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.eururo.2012.10.016","article-title":"Efficacy and tolerability of mirabegron, a beta(3)- adrenoceptor agonist, in patients with overactive bladder: results from a randomized European-Australian phase 3 trial","volume":"60","author":"Khullar","year":"2013","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.conctc.2026.101693_b24","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.juro.2012.10.017","article-title":"Results of a randomized phase III trial of mirabegron in patients with overactive bladder","volume":"189","author":"Nitti","year":"2013","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.conctc.2026.101693_b25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.urology.2013.02.077","article-title":"A phase III, randomized, double-blind, parallel-group, placebo-conrolled, multicentre study to assess the efficacy and safety of the \u03b23 adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder","volume":"82","author":"Herschorn","year":"2013","journal-title":"Urology"},{"issue":"21","key":"10.1016\/j.conctc.2026.101693_b26","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1002\/sim.5851","article-title":"Using historical control information for the design and analysis of clinical trials with overdispersed count data. Statistics in medicine","volume":"32","author":"Gsteiger","year":"2013","journal-title":"Stat. Med."},{"issue":"431","key":"10.1016\/j.conctc.2026.101693_b27","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1080\/01621459.1995.10476592","article-title":"A reference Bayesian test for nested hypotheses and its relationship to the Schwarz criterion","volume":"90","author":"Kass","year":"1995","journal-title":"J. Amer. Statist. Assoc."},{"key":"10.1016\/j.conctc.2026.101693_b28","article-title":"Including historical data in the analysis of clinical trials: Is it worth the effort?","author":"van Rosmalen","year":"2017","journal-title":"Stat. Methods Med. Res."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865426001006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865426001006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T15:48:32Z","timestamp":1792943312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865426001006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":28,"alternative-id":["S2451865426001006"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2026.101693","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inclusion of historical control data in the analysis of a current trial for zero-inflated count models","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2026.101693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101693"}}